DUBLIN–(BUSINESS WIRE)–The “Opioids
Market – Growth, Trends, and Forecast (2019-2024)” report has
been added to ResearchAndMarkets.com’s offering.
Due to an increase in the incidence of medical ailments, the market
studied is expected to grow over the forecast period.
Strong Agonists are Expected to Hold the Largest Market
Share in the Receptor Binding Segment
In the receptor binding segment of the opioids market, the strong
agonist category is expected to have the largest market size. This
segment is expected to witness a CAGR of 5.02% in the forecast period.
An agonist is a drug that triggers certain receptors in the brain.
Methadone (strong) agonist therapy is an effective treatment for
addiction to opioid drugs (such as heroin).
Strong agonist opioids activate opioid receptors, and after binding
tightly, undergo significant conformational changes. Strong agonists
include codeine, fentanyl, heroin, hydrocodone, methadone, morphine, and
oxycodone. As per the US Department of Health and Human Services and
National Institutes of Health, in 2015, 25.4 million Americans adults
experienced pain daily. This statistic indicates the importance of pain
management and impacts the opioid market positively.
North America Dominates the Market and is Expected to
Continue to Dominate in the Forecast Period
North America currently dominates the market for opioids and is expected
to continue its strong hold for a few more years. Codeine and morphine
are the most commonly prescribed opioids for cancer patients to relieve
pain. However, illegal use of fentanyl to relieve pain is rising across
the United States.
Recently, in 2018, despite the escalating trade war between the United
States and China, medical and law enforcement officials and politicians
tried to stop illegally mailed fentanyl from China to the United States.
Some of the major companies in the United States market include Teva,
Janssen, Insys, and Mylan. However, some of these companies have been
involved in legal actions instituted against them for persuading doctors
to influence sales of opioids to boost the market.
In the past two years, initiatives and campaigns have been initiated
under the Centers for Disease Control and Prevention and Federal
government to fight the opioid epidemic. Due to these actions, growth of
the studied market is expected to steadily slow down over the forecast
The opioids market consists of several players. In terms of market
share, few of the players currently dominate the market. However, with
the rising usage of the opioids in medicines, more companies are trying
to enter this market, especially in the emerging markets. However,
strict laws and stringent regulatory policies are deterring market
penetration by small- and mid-sized companies.
Allergan, Teva Pharmaceuticals, Mallinckrodt, Insys Therapeutics, and
Amneal Pharmaceuticals Inc. hold a substantial market share of the
Key Topics Covered
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Orthopedic Diseases & Chronic Pain
4.2.2 Inclination toward Extended Release Formulations from Immediate
Release of Opioids
4.2.3 Rising Focus on Abuse-deterrent Formulation (ADF) by Generic
4.2.4 Growing Palliative Care Facilities
4.3 Market Restraints
4.3.1 Advent and Legalization of Cannabis as an Alternative to Opioids
4.3.2 Prescription Drug Abuse
4.4 Porter’s Five Force Analysis
5 MARKET SEGMENTATION
5.1 Product Type
5.1.6 Other Product Types
5.2 Receptor Binding
5.2.1 Strong Agonist
5.2.2 Mild to Moderate Agonist
5.3.1 Pain Management
184.108.40.206 Cancer Pain
220.127.116.11 Neuropathic Pain
18.104.22.168 Osteoarthritis Pain
22.214.171.124 Other Pain Managements
5.3.2 Cold and Cough
5.3.4 Other Applications
5.4.1 North America
5.4.3 Asia Pacific
5.4.4 Middle East & Africa
5.4.5 South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan plc
6.1.2 Mallinckrodt LLC
6.1.3 Purdue Pharma L.P.
6.1.4 Rhodes Technologies L.P.
6.1.5 Sun Pharmaceutical Industries Ltd.
6.1.6 Teva Pharmaceutical
6.1.7 Vertice Pharma LLC
6.1.8 Johnson and Johnson
6.1.9 INSYS Therapeutics
6.1.10 Hikma Pharmaceuticals plc
6.1.11 Endo Pharmaceuticals Inc.
6.1.12 Egalet Corporation
6.1.13 Amneal Pharmaceuticals
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/4p1lz9
Laura Wood, Senior Press Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900